With the vigor and strength of the Ox, we greet the New Year—no need to spur us on; we’ll gallop forward all by ourselves. On the fourth day of the first lunar month, accompanied by the dawn’s first rays and the resounding beats of gongs and drums, employees of Shijiazhuang Fourth Pharmaceutical Co., Ltd., located along Zhujiang Avenue in Shijiazhuang High-tech Zone, stepped forth with vigorous strides. After undergoing temperature checks and scanning QR codes—a series of epidemic prevention procedures—they arrived at their workplaces early, brimming with confidence as they began to sweat profusely, determined to kick off the Year of the Ox with a stellar start.

▲ On the fourth day of the first lunar month, in Shijiazhuang High-tech Zone, management personnel from Shijiazhuang No.4 Pharmaceutical Company rang gongs and drums joyfully to welcome employees back to work after the holiday.

“A year’s plan starts with spring.” As you step into the various workshops of Shijiazhuang No.4 Pharmaceutical, you’ll see employees bustling about everywhere. Automated equipment hums cheerfully, and everywhere exudes a vibrant, bustling atmosphere.
“The recent epidemic put us through a severe test. To further strengthen our service and guarantee efforts in the pharmaceutical market, we’ll need to step up our efforts even more after the holiday,” said Wu Hengyao, President of Shijiazhuang Fourth Pharmaceutical. They’ve made systematic arrangements for production and sales following the holiday, shortening the Spring Festival break. Employees have also made considerable sacrifices for this purpose. Time waits for no one—so we need to quickly replenish our inventory to ensure that hospitals can resume normal and timely drug supplies after the holiday, striving to achieve a strong start to the first quarter.”

▲ On the fourth day of the first lunar month, employees of Shijiazhuang Fourth Pharmaceutical, accompanied by resounding gongs and drums, enthusiastically kicked off their work for the Year of the Ox in the Shijiazhuang Economic Development Zone.

In Workshop 104 of Sihua Pharmaceutical, the filling equipment on the sterile injection water ampoule production line is running at full speed. Neatly arranged products are rapidly streaming off the conveyor belt, eagerly heading toward the packaging stage and preparing to undergo the market’s “inspection.” Jiang Deguang, Deputy General Manager of the Shijiazhuang Sihua Pharmaceutical Manufacturing Center, explained that on the eve of the Spring Festival, due to factors such as shortages of raw materials and disruptions in logistics, the production line could only operate on a single shift. Now, these issues have been effectively resolved, and after the holiday, the production line has begun scheduling three consecutive shifts to do its utmost to meet market demand.
The brand-new doxofylline injection production line next door just underwent a GMP compliance inspection before the Spring Festival, and employees are now making the final preparations before official production begins.

▲ On the fourth day of the first lunar month, the water-injection preparation production line in Workshop 104 of Shijiazhuang No. 4 Pharmaceutical Company began production for the Year of the Ox.

Jiang Deguang said, “The Dextromethorphan Injection and Ambroxol Hydrochloride Injection are two new products that have recently passed the consistency evaluation. Before the Spring Festival, they both won bids in the fourth round of national centralized drug procurement tenders, marking a great start for us to ramp up production and expand our market share in the Year of the Ox.” These two winning products—Dextromethorphan Injection will be exclusively supplied to six provinces and cities: Hubei, Yunnan, Chongqing, Heilongjiang, Inner Mongolia, and Ningxia; while Ambroxol Hydrochloride Injection will be exclusively supplied to three provinces and cities: Shanghai, Tianjin, and Qinghai. Both products are key medications used during the peak winter and spring seasons for treating respiratory conditions, with extremely high market demand. Sales orders are fully booked, and many customers are eagerly awaiting stock replenishment.

▲ On the fourth day of the first lunar month, employees at the oral dosage form ingredient preparation station in Workshop 207 of Shijiazhuang No.4 Pharmaceutical Co., Ltd. were carefully monitoring the production operation status.

The abundant innovative achievements have given Shijiazhuang Fourth Pharmaceutical even greater confidence and momentum for its development in the Year of the Ox. Wu Hengyao proudly introduced that, over the past two years, Fourth Pharmaceutical has collaboratively advanced research and development of innovative drugs as well as studies on the consistency evaluation of generic drug quality and efficacy. With a strong focus on optimizing dosage-form structures, the company’s innovative efforts have placed it among the industry leaders. To date, 14 product specifications have successfully passed the national evaluation and obtained the “entry ticket” for the national centralized drug procurement. Half of these products are oral formulations. Last year, during the nation’s third round of centralized drug procurement, Cefdinir capsules and Pregabalin succinate tablets both won bids in first place, significantly enhancing the market influence of Fourth Pharmaceutical’s oral products. This year, the company is poised to receive approval for several new flagship oral products. In the near future, the situation where intravenous infusions dominated Fourth Pharmaceutical’s business will be rewritten, and oral formulations will become a key growth driver for the company’s future profitability.

▲ On the fourth day of the first lunar month, employees at the oral dosage form packaging station in Workshop 207 of Shijiazhuang No.4 Pharmaceutical Co., Ltd. were carefully operating the production equipment.

“A person’s entire life depends on diligence.” At Workshop 207 of Siyao in the Shijiazhuang Economic and Technological Development Zone, employees finish their preparatory work before 7:30 a.m., and the production line is “fully ready to go.” Here, as the “fast-forward button” for Year of the Ox production is pressed, more than ten processes—from material preparation and ingredient mixing to filling, aluminum-plastic packaging, machine assembly, inspection, sealing, and boxing—work together precisely, efficiently, and in an orderly manner to ensure the smooth operation of oral dosage form production.

On the fourth day of the first lunar month, tech professionals at Shijiazhuang No.4 Pharmaceutical R&D Center set off on their innovative journey for the Year of the Ox, greeted by the rising sun and a gentle spring breeze.

“Our workshop is responsible for supplying nationally and locally tendered products that have won centralized procurement bids. The purchase volumes are huge, and the delivery deadlines are tight. Precisely because of this, we must strictly adhere to the process requirements—there can be absolutely no room for even the slightest carelessness in the production process. Every single product must stand up to the rigorous scrutiny of the market,” said Yang Yuxia, the workshop director. “Our production workload is heavy; otherwise, it would hold back our sales. Especially in the Year of the Ox, we need to step up our efforts even more.”